Nationwide retrospective review of hematopoietic stem cell transplantation in children with refractory Langerhans cell histiocytosis

[1]  J. Quinn,et al.  CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH‐associated neurodegeneration and mass lesions , 2018, Cancer.

[2]  S. Zimmermann,et al.  Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature , 2018, Oncotarget.

[3]  Y. Tsunematsu,et al.  Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study , 2018, International Journal of Hematology.

[4]  M. Oda,et al.  A Case of Refractory Langerhans Cell Histiocytosis Complicated with Hemophagocytic Lymphohistiocytosis Rescued by Cord Blood Transplantation with Reduced-intensity Conditioning. , 2017, Acta medica Okayama.

[5]  Y. Tsunematsu,et al.  Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study , 2016, International Journal of Hematology.

[6]  M. V. van Noesel,et al.  Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study. , 2015, Blood.

[7]  C. Allen,et al.  How I treat Langerhans cell histiocytosis. , 2015, Blood.

[8]  A. Fischer,et al.  Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning , 2015, British journal of haematology.

[9]  U. Pötschger,et al.  Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. , 2013, Blood.

[10]  S. Ohga,et al.  Improved outcome of refractory Langerhans cell histiocytosis in children with hematopoietic stem cell transplantation in Japan , 2010, Bone Marrow Transplantation.

[11]  H. Tsutsumi,et al.  Successful treatment of refractory Langerhans cell histiocytosis with pulmonary aspergillosis by reduced‐intensity conditioning cord blood transplantation , 2010, Pediatric transplantation.

[12]  B. Sandmaier,et al.  Defining the intensity of conditioning regimens: working definitions. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[13]  U. Pötschger,et al.  Improved outcome in multisystem Langerhans cell histiocytosis is associated with therapy intensification. , 2008, Blood.

[14]  K. Kawa,et al.  Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System , 2007, International journal of hematology.

[15]  Y. Tsunematsu,et al.  Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis , 2006, Cancer.

[16]  A. Attarbaschi,et al.  Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning , 2005, Bone Marrow Transplantation.

[17]  K. Yamada,et al.  Hematopoietic stem cell transplantation (HSCT) for Langerhans cell histiocytosis (LCH) in Japan , 1999, Bone Marrow Transplantation.

[18]  G. Gahrton,et al.  Allogeneic bone marrow transplantation in a patient with chemotherapy-resistant progressive histiocytosis X. , 1987, The New England journal of medicine.

[19]  Y. Atsuta.  Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data) , 2015, International Journal of Hematology.

[20]  T. Lion,et al.  Importance of allogeneic T-cells for disease control after stem cell transplantation for high-risk Langerhans cell histiocytosis. , 2007, Haematologica.

[21]  L. Dehner.  Allogeneic bone marrow transplantation in a patient with chemotherapy-resistant progressive histiocytosis X. , 1987, New England Journal of Medicine.